Literature DB >> 11515818

Mast cells as a source and target for nitric oxide.

M Bidri1, F Féger, S Varadaradjalou, N Ben Hamouda, J J Guillosson, M Arock.   

Abstract

Mast cells (MC), which are tissue-resident cells found widely distributed in the body, are derived from primitive hematopoietic cells. MC produce a variety of biologically active substances such as histamine, proteases, lipid derivatives and numerous cytokines and chemokines in response to immunologic or non-immunologic stimuli. Of interest, it has been reported that rodent MC can also be a source of nitric oxide (NO) derivatives, that they synthesize spontaneously, or only after activation, depending on their subtype. This synthesis appears to be under the control of the expression of the inducible isoform of the nitric oxide synthase (iNOS) and of the constitutive neuronal NOS (nNOS). MC might thus be able to influence the survival and functions of other types of NO-sensitive cells in close vicinity. Apart from being a source of NO, MC can also be the target for NO and its derivatives. Indeed, survival and reactivity of rodent MC is influenced by NO derivatives produced by MC themselves or by other cellular elements in close contact with the MC in tissues. By contrast, the existence of such mechanisms of cross-talk between MC and NO remains poorly documented in humans. If evidence are supplied in favor of such relationship, pharmacological modulation by agents acting at the level of the NO pathway might be of interest in order to regulate the functions of MC in immunologic, neoplastic, inflammatory and other conditions.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11515818     DOI: 10.1016/s1567-5769(01)00097-2

Source DB:  PubMed          Journal:  Int Immunopharmacol        ISSN: 1567-5769            Impact factor:   4.932


  14 in total

Review 1.  Nitric oxide: a regulator of mast cell activation and mast cell-mediated inflammation.

Authors:  J W Coleman
Journal:  Clin Exp Immunol       Date:  2002-07       Impact factor: 4.330

2.  Remodeling of the guinea pig intrinsic cardiac plexus with chronic pressure overload.

Authors:  Jean C Hardwick; Caitlin N Baran; E Marie Southerland; Jeffrey L Ardell
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2009-07-15       Impact factor: 3.619

3.  Cross talk between polysulfide and nitric oxide in rat peritoneal mast cells.

Authors:  Amira Moustafa; Yoshiaki Habara
Journal:  Am J Physiol Cell Physiol       Date:  2016-04-06       Impact factor: 4.249

Review 4.  Role of endothelial nitric oxide in cerebrovascular regulation.

Authors:  Dmitriy N Atochin; Paul L Huang
Journal:  Curr Pharm Biotechnol       Date:  2011-09       Impact factor: 2.837

5.  Vascular and perivascular nitric oxide release and transport: biochemical pathways of neuronal nitric oxide synthase (NOS1) and endothelial nitric oxide synthase (NOS3).

Authors:  Kejing Chen; Aleksander S Popel
Journal:  Free Radic Biol Med       Date:  2006-12-14       Impact factor: 7.376

6.  Hydrogen inhalation ameliorated mast cell-mediated brain injury after intracerebral hemorrhage in mice.

Authors:  Anatol Manaenko; Tim Lekic; Qingyi Ma; John H Zhang; Jiping Tang
Journal:  Crit Care Med       Date:  2013-05       Impact factor: 7.598

7.  Chronic myocardial infarction induces phenotypic and functional remodeling in the guinea pig cardiac plexus.

Authors:  Jean C Hardwick; E Marie Southerland; Jeffrey L Ardell
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2008-10-01       Impact factor: 3.619

Review 8.  Role of nitric oxide in mast cells: controversies, current knowledge, and future applications.

Authors:  Yokananth Sekar; Tae Chul Moon; Samira Muñoz; A Dean Befus
Journal:  Immunol Res       Date:  2005       Impact factor: 2.829

Review 9.  Eosinophils and mast cells in leishmaniasis.

Authors:  Nilda E Rodríguez; Mary E Wilson
Journal:  Immunol Res       Date:  2014-08       Impact factor: 2.829

10.  Inhibition of anti-IgE mediated human mast cell activation by NO donors is dependent on their NO release kinetics.

Authors:  K H Yip; F P Leung; Y Huang; H Y A Lau
Journal:  Br J Pharmacol       Date:  2009-03-19       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.